RMOCX
Price
$15.26
Change
-$0.05 (-0.33%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

RMOCX vs RPTIX

Header iconRMOCX vs RPTIX Comparison
Open Charts RMOCX vs RPTIXBanner chart's image
Victory RS Mid Cap Growth C
Price$15.26
Change-$0.05 (-0.33%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RMOCX vs RPTIX Comparison Chart
Loading...
VS
RMOCX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMOCX is a Buy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. RMOCX (73.1M). RPTIX pays higher dividends than RMOCX: RPTIX (0.18) vs RMOCX (0.00). RMOCX was incepted earlier than RPTIX: RMOCX (17 years) vs RPTIX (9 years). RMOCX is a more actively managed with annual turnover of: 119.00 vs. RPTIX (21.70). RMOCX has a lower initial minimum investment than RPTIX: RMOCX (2500) vs RPTIX (500000). RMOCX annual gain was more profitable for investors over the last year : 22.68 vs. RPTIX (14.81). RPTIX return over 5 years is better than : 15.09 vs. RMOCX (-29.48).
RMOCXRPTIXRMOCX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years9 years-
Gain YTD10.4629.127115%
Front LoadN/AN/A-
Min. Initial Investment25005000001%
Min. Initial Investment IRAN/AN/A-
Net Assets73.1M31.4B0%
Annual Yield % from dividends0.000.18-
Returns for 1 year22.6814.81153%
Returns for 3 years-46.09-13.57340%
Returns for 5 years-29.4815.09-195%
Returns for 10 years-12.81N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp